You have 8 free searches left this month | for more free features.

Angiotensin-converting enzyme inhibitors (ACE)

Showing 1 - 25 of 7,591

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chagas Cardiomyopathy Trial in São Paulo (Sacubitril / Valsartan Oral Tablet [Entresto], Enalapril)

Recruiting
  • Chagas Cardiomyopathy
  • Sacubitril / Valsartan Oral Tablet [Entresto]
  • Enalapril
  • São Paulo, Brazil
    Heart Institute (Incor) University of Sao Paulo
May 6, 2021

Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)

Recruiting
  • Kidney Disease
  • Chula Vista, California
  • +5 more
Jan 23, 2023

Coronavirus Disease 2019 Patients Receiving Receiving

Completed
  • COVID-19
  • Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Angiotensin II Receptor Blockers (ARB)
  • Riyadh, Saudi Arabia
    King Faisal Specialist Hospital & Research Centre
Aug 1, 2020

Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor Trial in Saint Louis (High ACE Activity Fresh Frozen Plasma, Normal

Recruiting
  • Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor
  • High ACE Activity Fresh Frozen Plasma
  • Normal Saline
  • Saint Louis, Missouri
    Barnes-Jewish Hospital
Oct 24, 2022

Tranexamic Acid for Angiotensin-converting Enzyme

Completed
  • Angioedema
    • Dallas, Texas
      Methodist Dallas Medical Center
    Oct 17, 2023

    Angiotensin Converting Enzyme Inhibitors and Angiotensin

    Not yet recruiting
    • COVID-19 Pneumonia
    • Covid_19
    • (no location specified)
    Jun 5, 2022

    Diabetes, Cardiovascular Diseases Trial in Singapore (Renin-angiotensin-aldosterone system inhibitors, Beta blocker, SGLT2

    Recruiting
    • Diabetes Mellitus
    • Cardiovascular Diseases
    • Renin-angiotensin-aldosterone system inhibitors
    • +2 more
    • Singapore, Singapore
      Singapore General Hospital (SGH)
    Apr 28, 2021

    Angiotensin Converting Enzyme Inhibitors and Incident

    Unknown status
    • Covid-19, Coronavirus, Angiotensin Converting Enzyme Inhibitors, Influenza, Electronic Health Records, Epidemiology, Comorbidity, Incidence, United Kingdom
    • ACE inhibitor
    • (no location specified)
    Nov 11, 2020

    Bradykinin-degradating Enzymes Activities in

    Recruiting
    • Angio-Oedema Caused by Angiotensin-Converting-Enzyme Inhibitor
    • Assay of Bradykinin-degradating enzymes.
    • Grenoble, France
      Chu Grenoble Alpes
    Jan 14, 2022

    Therapeutic Drug Use for CKD Patients

    Active, not recruiting
    • Chronic Kidney Disease
    • angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
    • Jinan, Shandong, China
      Xiao Li,MD
    Apr 18, 2023

    Hydrochlorothiazide and Risk of Skin Cancer

    Completed
    • Non-melanoma Skin Cancer
    • +2 more
    • Montreal, Quebec, Canada
      Centre for Clinical Epidemiology, Lady Davis Institute, Jewish G
    Mar 8, 2021

    Vascular Access Complication Trial in Rawalpindi (Losartan Potassium, multi-vitamins)

    Recruiting
    • Vascular Access Complication
    • Rawalpindi, Punjab, Pakistan
      Anas Bin Saif
    Nov 22, 2021

    Angiotensin Converting Enzyme rs Gene Polymorphism and

    Recruiting
    • Angiotensin Converting Enzyme rs (1799752) Gene Polymorphism and Development of In-Stent Restenosis in Patients With Stable Coronary Artery Diseases
    • DNA extraction AND Real- time polymerase chain reaction analysis to POLYMORPHISM OF in in-stent restenosis (ISR) in CAD
    • Sohag, Egypt
      Sohag university Hospital
    Sep 20, 2023

    Type 2 Diabetes, Hypertension Trial in Nashville (Placebo, Sitagliptin, Aprepitant)

    Completed
    • Type 2 Diabetes Mellitus
    • Hypertension
    • Placebo
    • +3 more
    • Nashville, Tennessee
      Vanderbilt University
    Feb 8, 2022

    Chronic Kidney Diseases Trial (Placebo, Co-Enzyme Q10)

    Not yet recruiting
    • Chronic Kidney Diseases
    • Placebo
    • Co-Enzyme Q10
    • (no location specified)
    Jul 4, 2023

    Angiotensin Converting Enzyme in Systemic Lupus Erythematous

    Not yet recruiting
    • Systemic Lupus Erythematosus
    • Angiotensin Converting Enzyme test
    • Sohag, Egypt
      Sohag University Hospital
    Aug 24, 2022

    Precision Treatment With Angiotensin Converting Enzyme Inhibitor

    Recruiting
    • Hypertension
    • +2 more
      • Seoul, Korea, Republic of
        Yonsei University Health System, Severance Hospital
      Sep 7, 2022

      AML, Acute Myeloid Leukemia Trial in Charlottesville (Cardioprotection)

      Recruiting
      • AML
      • Acute Myeloid Leukemia
      • Charlottesville, Virginia
        University of Virginia
      Jul 2, 2022

      Diabetic Nephropathy Type 2 Trial (Empagliflozin 25 MG, Enalapril Maleate 20 mg)

      Not yet recruiting
      • Diabetic Nephropathy Type 2
      • Empagliflozin 25 MG
      • Enalapril Maleate 20 mg
      • (no location specified)
      May 9, 2022

      Surgery, Angiotensin Hypertension, Perioperative Complication Trial in Netherlands (drug, diagnostic test, behavioral)

      Recruiting
      • Surgery
      • +2 more
      • Perioperative withdrawal of angiotensin converting enzyme inhibitors and angiotenin receptor blockers
      • +4 more
      • Amsterdam, Netherlands
      • +6 more
      Jan 6, 2022

      Chronic Kidney Diseases Trial (Placebo, Vitamin K 2)

      Not yet recruiting
      • Chronic Kidney Diseases
      • Placebo
      • Vitamin K 2
      • (no location specified)
      Jul 4, 2023

      Cardiovascular Disease, Chronic Kidney Disease Trial in Madison (angiotensin converting enzyme inhibitor, lisinopril)

      Completed
      • Cardiovascular Disease
      • Chronic Kidney Disease
      • Madison, Wisconsin
        University of Wisconsin-Madison Hospitals and Clinics
      Oct 8, 2020

      Angiotensin Converting Enzyme, Brain, Gut Dysbiosis in Pulmonary

      Active, not recruiting
      • Pulmonary Arterial Hypertension
        • Jacksonville, Florida
        • +1 more
        Jan 10, 2022

        Aortic Valve Stenosis Trial in Seoul (Angiotensin Receptor-Neprilysin Inhibitor, antihypertensive drugs including RAS inhibitors

        Not yet recruiting
        • Aortic Valve Stenosis
        • Angiotensin Receptor-Neprilysin Inhibitor
        • antihypertensive drugs including RAS inhibitors (ACE inhibitors or ARB)
        • Seoul, Korea, Republic of
          Asan Medical Center
        Jan 4, 2023

        COVID-19, Cardiovascular Diseases Trial in Brazil, Canada, Mexico (Angiotensin converting enzyme inhibitor, Angiotensin II

        Recruiting
        • COVID-19
        • Cardiovascular Diseases
        • Angiotensin converting enzyme inhibitor
        • Angiotensin II Receptor Blockers
        • Maceio, Alagoas, Brazil
        • +30 more
        Jan 13, 2023